Rajeev Ramanathan

722 total citations
17 papers, 575 citations indexed

About

Rajeev Ramanathan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Rajeev Ramanathan has authored 17 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Rajeev Ramanathan's work include Protist diversity and phylogeny (7 papers), Photoreceptor and optogenetics research (5 papers) and Plant and Biological Electrophysiology Studies (2 papers). Rajeev Ramanathan is often cited by papers focused on Protist diversity and phylogeny (7 papers), Photoreceptor and optogenetics research (5 papers) and Plant and Biological Electrophysiology Studies (2 papers). Rajeev Ramanathan collaborates with scholars based in United States, Japan and Switzerland. Rajeev Ramanathan's co-authors include David Lee Nelson, Roland R. Dute, C Kung, Chris Reading, K.‐Y. Ling, A Adoutte, Robert M. Lewis, Elie G. Hanania, Michael Forte and Mihoko Takahashi and has published in prestigious journals such as Cell, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Rajeev Ramanathan

17 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajeev Ramanathan United States 12 378 130 116 90 77 17 575
Ruchika Gupta United States 7 495 1.3× 107 0.8× 188 1.6× 53 0.6× 34 0.4× 9 632
CE Myers United States 9 216 0.6× 113 0.9× 47 0.4× 35 0.4× 52 0.7× 10 451
R. C. Nicholson Australia 10 661 1.7× 197 1.5× 91 0.8× 51 0.6× 60 0.8× 11 1.0k
Daniel P. Kestler United States 15 423 1.1× 77 0.6× 182 1.6× 20 0.2× 32 0.4× 38 738
Hans-Jörg Warnatz Germany 12 529 1.4× 74 0.6× 106 0.9× 18 0.2× 49 0.6× 15 766
H. Busch United States 8 738 2.0× 148 1.1× 58 0.5× 12 0.1× 69 0.9× 11 932
Hirohiko Yajima Japan 13 857 2.3× 293 2.3× 179 1.5× 56 0.6× 19 0.2× 19 1.0k
Zahide Özer United States 14 265 0.7× 135 1.0× 59 0.5× 17 0.2× 94 1.2× 23 583
Liliana Guzman‐Rojas United States 17 407 1.1× 255 2.0× 33 0.3× 83 0.9× 24 0.3× 23 779
Stéphanie Boireau France 13 867 2.3× 94 0.7× 77 0.7× 17 0.2× 82 1.1× 22 1.0k

Countries citing papers authored by Rajeev Ramanathan

Since Specialization
Citations

This map shows the geographic impact of Rajeev Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajeev Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajeev Ramanathan more than expected).

Fields of papers citing papers by Rajeev Ramanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajeev Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajeev Ramanathan. The network helps show where Rajeev Ramanathan may publish in the future.

Co-authorship network of co-authors of Rajeev Ramanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Rajeev Ramanathan. A scholar is included among the top collaborators of Rajeev Ramanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajeev Ramanathan. Rajeev Ramanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
O’Brien, Peter J., Rajeev Ramanathan, Jonathan M. Yingling, et al.. (2008). Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.. PubMed. 2(3). 563–9. 12 indexed citations
2.
O’Bryant, Cindy L., S. Hariharan, Siew Hong Leong, et al.. (2006). 412 POSTER An open-label study to characterize the pharmacokinetic (pk) parameters of erlotinib in patients with advanced solid tumors with adequate or moderately imparied hepatic function. European Journal of Cancer Supplements. 4(12). 126–127. 1 indexed citations
3.
Mulkerin, Daniel, Scot C. Remick, Rajeev Ramanathan, et al.. (2006). A dose-escalating and pharmacologic study of bortezomib in adult cancer patients with impaired renal function. Journal of Clinical Oncology. 24(18_suppl). 2032–2032. 17 indexed citations
4.
Marshall, John L., Sundar Ramalingam, Jimmy J. Hwang, et al.. (2005). Phase 1 and pharmacokinetic (PK) study of weekly KOS-862 (Epothilone D) combined with gemcitabine (GEM) in patients (Pts) with advanced solid tumors. Journal of Clinical Oncology. 23(16_suppl). 2041–2041. 11 indexed citations
5.
Zehnder, James L., et al.. (1999). Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD). Leukemia. 13(11). 1833–1842. 45 indexed citations
6.
Deutsch, Melvin, et al.. (1999). Pancreatic Cancer in a Young Adult After Treatment for Hodgkin's Disease. Clinical Oncology. 11(4). 280–282. 4 indexed citations
7.
Ramanathan, Rajeev, et al.. (1998). Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.. PubMed. 58(17). 3957–64. 100 indexed citations
8.
Shin, Seung-Uon, et al.. (1997). Functional and pharmacokinetic properties of antibody-avidin fusion proteins. The Journal of Immunology. 158(10). 4797–4804. 31 indexed citations
9.
Uchida, Nobuko, Zhi Yang, Olivier Pourquié, et al.. (1997). The Characterization, Molecular Cloning, and Expression of a Novel Hematopoietic Cell Antigen From CD34+ Human Bone Marrow Cells. Blood. 89(8). 2706–2716. 66 indexed citations
10.
Belani, Chandra P., et al.. (1995). Pharmacokinetics of paclitaxel and carboplatin in combination.. PubMed. 22(5 Suppl 12). 1–4; discussion 5. 22 indexed citations
11.
Haga, Nobuyuki, Michael Forte, Rajeev Ramanathan, et al.. (1984). Characterization and purification of a soluble protein controlling Ca-channel activity in paramecium. Cell. 39(1). 71–78. 37 indexed citations
12.
Haga, Nobuyuki, Michael Forte, Rajeev Ramanathan, et al.. (1984). Purification of a Soluble Protein Controlling Ca++ Channel Activity in Paramecium. Biophysical Journal. 45(1). 130–132. 8 indexed citations
13.
Ramanathan, Rajeev, Yoshiro Saimi, Joan B. Peterson, David Lee Nelson, & C Kung. (1983). Antibodies to the ciliary membrane of Paramecium tetraurelia alter membrane excitability.. The Journal of Cell Biology. 97(5). 1421–1428. 10 indexed citations
14.
Eisenbach, Lea, Rajeev Ramanathan, & David Lee Nelson. (1983). Biochemical studies of the excitable membrane of paramecium tetraurelia. IX. Antibodies against ciliary membrane proteins.. The Journal of Cell Biology. 97(5). 1412–1420. 18 indexed citations
15.
Adoutte, A, K.‐Y. Ling, Michael Forte, et al.. (1981). Ionic channels of Paramecium: from genetics and electrophysiology to biochemistry.. PubMed. 77(9). 1145–59. 13 indexed citations
16.
Ramanathan, Rajeev, André Adoutte, & Roland R. Dute. (1981). Biochemical studies of the excitable membrane of Paramecium tetraurelia. V. effects of proteases on the ciliary membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 641(2). 349–365. 15 indexed citations
17.
Adoutte, A, Rajeev Ramanathan, Robert M. Lewis, et al.. (1980). Biochemical studies of the excitable membrane of Paramecium tetraurelia. III. Proteins of cilia and ciliary membranes.. The Journal of Cell Biology. 84(3). 717–738. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruchika Gupta Breakdown of academic impact, for papers by CE Myers Breakdown of academic impact, for papers by R. C. Nicholson Breakdown of academic impact, for papers by Daniel P. Kestler Breakdown of academic impact, for papers by Hans-Jörg Warnatz Breakdown of academic impact, for papers by H. Busch Breakdown of academic impact, for papers by Hirohiko Yajima Breakdown of academic impact, for papers by Zahide Özer Breakdown of academic impact, for papers by Liliana Guzman‐Rojas Breakdown of academic impact, for papers by Stéphanie Boireau
Rankless by CCL
2026